NEW YORK, July 22, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
New to Insight Pharma Reports is Molecular Biomarkers for Cancer Detection and Management: Technologies, Markets, and Trends. This report focuses on recent progress and new directions in this highly dynamic diagnostic field. Covering extensive background and history, commercialization, and marketing trends of cancer biomarker technologies, this report provides heavy detail of historical and evolutionary aspects of cancer biomarkers, delineating some of the difficulties researchers face in validating and commercializing their candidate assays.
Significant highlights of the report include: • Basic research conducted in both academic and commercial settings divided into three segments: disease detection, prognosis, and companion diagnostics.
- 42 detailed descriptions of copmanies (including GenomeDx Biosciences, Genomic Health, Life Technologies, Foundation Medicine, Roche Molecular Systems, and many more!).
• Commercial activity in the three foregoing sectors, and the perspective of market dynamics.
• Focuses on trends and conclusions.
• Data depicted across 15 tables and figures.
Following company descriptions and commercial applications are transcribed interviews of five individuals who are highly knowledgeable in the field, including: • Genome Diagnostics
• Billings Clinic
• Scientia Advis
Copyright©2012 PR Newswire.
All rights reserved